Happy New Year to everyone! We wish you, your family, friends and companies a very prosperous year.
Thank you for visiting Sunsho Pharmaceutical’s website! Winter has finally arrived in the Fuji and Fujinomiya region, which faces the Pacific Ocean and enjoys a relatively mild climate. This year, due to frequent rain at the end of the year, snow has settled, creating a stunning snowy view of sacred Mt. Fuji. This is the season when Mt. Fuji is at its best. We warmly invite you to visit our home region of Fuji and Fujinomiya.
The OECD forecasts that the global economy will return to a growth trajectory through 2026. This outlook appears to be supported by factors such as the easing impact of high tariffs, expansionary macroeconomic policies, and increased investment in sectors that underpin the use of artificial intelligence (AI). In Japan, economic conditions are expected to be sustained - or even boosted - by fiscal management under the Takaichi administration, which advocates ‘responsible proactive fiscal policy,’ as well as improvements in household income through wage increases.
As the economy recovers, the health food industry is also expected to return to pre-incident levels prior to the red yeast rice issue two years ago. In fact, we are already seeing signs of recovery in existing product sales, along with active efforts to launch new products. At the same time, this year marks the full implementation of regulatory changes, including mandatory GMP compliance, triggered by the red yeast rice incident. As a leading contract development and manufacturing company, we aim to take the lead in ensuring consumer confidence in safety and security, while contributing to the sound growth of the health food market.
In accordance with our mission to contribute to the mental and physical well-being of people around the world, we will continue working as one team to earn recognition as your best partner again in 2026. We sincerely look forward to working with our partners and customers.
January 5, 2025
Row Imamura, CEO